Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells

Salvage radiotherapy (SRT) is the first-line treatment for prostate cancer patients with biochemical recurrence following radical prostatectomy, and new specific radiosensitizers are in urgent need to enhance SRT effect. MLN4924 (also known as Pevonedistat), a specific inhibitor of NEDD8-activating...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaofang, Zhang, Wenjuan, Yan, Zi, Liang, Yupei, Li, Lihui, Yu, Xiaoli, Feng, Yan, Fu, Shen, Zhang, Yanmei, Zhao, Hu, Yu, Jinha, Jeong, Lak Shin, Guo, Xiaomao, Jia, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122397/
https://www.ncbi.nlm.nih.gov/pubmed/27224919
http://dx.doi.org/10.18632/oncotarget.9526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122397/
https://www.ncbi.nlm.nih.gov/pubmed/27224919
http://dx.doi.org/10.18632/oncotarget.9526

Ejemplares similares